Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NeuroBo Pharmaceuticals, Inc. - Common Stock
(NQ:
NRBO
)
2.360
UNCHANGED
Last Price
Updated: 3:59 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.360
Bid (Size)
2.310 (1)
Ask (Size)
2.680 (17)
Prev. Close
2.360
Today's Range
2.360 - 2.360
52wk Range
2.080 - 6.750
Shares Outstanding
8,616,010
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
December 03, 2024
Via
ACCESSWIRE
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
November 15, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
-6.72%
-6.72%
6 Month
-51.14%
-51.14%
1 Year
-30.99%
-30.99%
More News
Read More
Life Sciences Investor Forum Agenda Announced for November 14th
November 12, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event
November 11, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
June 26, 2024
Via
Benzinga
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
May 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 22, 2024
Via
Benzinga
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via
Benzinga
The Top 3 Stocks to Watch This Week
February 05, 2024
Via
InvestorPlace
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
February 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 01, 2024
Via
Benzinga
Stocks Rise Amid Flood Of Economic Data
February 01, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
February 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
February 01, 2024
Via
Investor Brand Network
Exposures
COVID-19
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
February 01, 2024
Via
Benzinga
Exposures
Product Safety
Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000
February 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?
December 29, 2023
Via
Benzinga
Life Science Investor Forum: Presentations Now Available for Online Viewing
December 15, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
December 12, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
